|Podcasts|September 30, 2021
Episode 92: Digesting the GI Market
Author(s)Elaine Quilici, Miranda Schmalfuhs
Advertisement
Tom McCourt, CEO of Ironwood Pharmaceuticals, discusses his extensive background in gastrointestinal drug development, the current landscape of therapies, and what the future may hold for this space.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
2
Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D
3
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
4
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
5